BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mendonça DV, Tavares GS, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PA, Ottoni FM, Antinarelli LM, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Chávez-fumagalli MA, Roatt BM, Menezes-souza D, Barichello JM, Alves RJ, Coelho EA. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection. Biomedicine & Pharmacotherapy 2019;109:779-87. [DOI: 10.1016/j.biopha.2018.10.143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Singh V, Eljaaly K, Md S, Alhakamy NA, Kesharwani P. Triblock copolymeric drug delivery as an emerging nanocarrier for treatment of infectious diseases. Journal of Drug Delivery Science and Technology 2022;75:103691. [DOI: 10.1016/j.jddst.2022.103691] [Reference Citation Analysis]
2 Machado AS, Lage DP, Vale DL, Freitas CS, Linhares FP, Cardoso JMO, Pereira IAG, Ramos FF, Tavares GSV, Ludolf F, Oliveira-da-Silva JA, Bandeira RS, Simões AC, Duarte MC, Oliveira JS, Christodoulides M, Chávez-Fumagalli MA, Roatt BM, Martins VT, Coelho EAF. A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum. Acta Trop 2022;230:106412. [PMID: 35305943 DOI: 10.1016/j.actatropica.2022.106412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ramos-Milaré ÁCFH, Oyama J, Murase LS, Souza JVP, Guedes BS, Lera-Nonose DSSL, Monich MT, Brustolin AÁ, Demarchi IG, Teixeira JJV, Lonardoni MVC. The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies. Parasitol Res 2022. [PMID: 35190878 DOI: 10.1007/s00436-022-07455-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mendonça DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Chávez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF. Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. Exp Parasitol 2021;:108205. [PMID: 34968460 DOI: 10.1016/j.exppara.2021.108205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Toscanini MA, Limeres MJ, Garrido AV, Cagel M, Bernabeu E, Moretton MA, Chiappetta DA, Cuestas ML. Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases. Journal of Drug Delivery Science and Technology 2021;66:102927. [DOI: 10.1016/j.jddst.2021.102927] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Erasmus C, Aucamp J, Smit FJ, Seldon R, Jordaan A, Warner DF, N'Da DD. Synthesis and comparison of in vitro dual anti-infective activities of novel naphthoquinone hybrids and atovaquone. Bioorg Chem 2021;114:105118. [PMID: 34216896 DOI: 10.1016/j.bioorg.2021.105118] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. Med Microbiol Immunol 2021;210:133-47. [PMID: 33870453 DOI: 10.1007/s00430-021-00707-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Freitas CS, Lage DP, Oliveira-da-Silva JA, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Duarte MC, Gonçalves DU, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis. Parasite 2021;28:38. [PMID: 33851916 DOI: 10.1051/parasite/2021036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hwang D, Ramsey JD, Kabanov AV. Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. Adv Drug Deliv Rev 2020;156:80-118. [PMID: 32980449 DOI: 10.1016/j.addr.2020.09.009] [Cited by in Crossref: 68] [Cited by in F6Publishing: 81] [Article Influence: 34.0] [Reference Citation Analysis]
10 Herrera L, Llanes A, Álvarez J, Degracia K, Restrepo CM, Rivera R, Stephens DE, Dang HT, Larionov OV, Lleonart R, Fernández PL. Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection. Int J Parasitol Drugs Drug Resist 2020;14:56-61. [PMID: 32950020 DOI: 10.1016/j.ijpddr.2020.08.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Tavares GSV, Mendonça DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Chávez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF. A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model. Parasite 2020;27:29. [PMID: 32351209 DOI: 10.1051/parasite/2020027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
12 Martínez-Rodrigo A, S Dias D, Ribeiro PAF, Roatt BM, Mas A, Carrión J, Coelho EAF, Domínguez-Bernal G. Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice. Vaccines (Basel) 2019;7:E183. [PMID: 31739549 DOI: 10.3390/vaccines7040183] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Gemili M, Nural Y, Keleş E, Aydıner B, Seferoğlu N, Ülger M, Şahin E, Erat S, Seferoğlu Z. Novel highly functionalized 1,4-naphthoquinone 2-iminothiazole hybrids: Synthesis, photophysical properties, crystal structure, DFT studies, and anti(myco)bacterial/antifungal activity. Journal of Molecular Structure 2019;1196:536-46. [DOI: 10.1016/j.molstruc.2019.06.087] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
14 Vigato AA, Querobino SM, de Faria NC, Candido ACBB, Magalhães LG, Cereda CMS, Tófoli GR, Campos EVR, Machado IP, Fraceto LF, de Sairre MI, de Araujo DR. Physico-Chemical Characterization and Biopharmaceutical Evaluation of Lipid-Poloxamer-Based Organogels for Curcumin Skin Delivery. Front Pharmacol 2019;10:1006. [DOI: 10.3389/fphar.2019.01006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sousa JKT, Antinarelli LMR, Mendonça DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Chávez-Fumagalli MA, Brandão GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitol Int 2019;73:101966. [PMID: 31362122 DOI: 10.1016/j.parint.2019.101966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]